CPHI
Price
$1.60
Change
-$0.06 (-3.59%)
Updated
Sep 8, 12:39 PM (EDT)
Capitalization
5.46M
MKKGY
Price
$25.77
Change
+$0.42 (+1.66%)
Updated
Sep 5 closing price
Capitalization
55.52B
66 days until earnings call
Interact to see
Advertisement

CPHI vs MKKGY

Header iconCPHI vs MKKGY Comparison
Open Charts CPHI vs MKKGYBanner chart's image
China Pharma Holdings
Price$1.60
Change-$0.06 (-3.59%)
Volume$500
Capitalization5.46M
Merck KGaA
Price$25.77
Change+$0.42 (+1.66%)
Volume$72.39K
Capitalization55.52B
CPHI vs MKKGY Comparison Chart in %
Loading...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPHI vs. MKKGY commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPHI is a Hold and MKKGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CPHI: $1.67 vs. MKKGY: $25.77)
Brand notoriety: CPHI and MKKGY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CPHI: 68% vs. MKKGY: 51%
Market capitalization -- CPHI: $5.46M vs. MKKGY: $55.52B
CPHI [@Pharmaceuticals: Generic] is valued at $5.46M. MKKGY’s [@Pharmaceuticals: Generic] market capitalization is $55.52B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPHI’s FA Score shows that 0 FA rating(s) are green whileMKKGY’s FA Score has 1 green FA rating(s).

  • CPHI’s FA Score: 0 green, 5 red.
  • MKKGY’s FA Score: 1 green, 4 red.
According to our system of comparison, both CPHI and MKKGY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPHI’s TA Score shows that 6 TA indicator(s) are bullish while MKKGY’s TA Score has 2 bullish TA indicator(s).

  • CPHI’s TA Score: 6 bullish, 4 bearish.
  • MKKGY’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CPHI is a better buy in the short-term than MKKGY.

Price Growth

CPHI (@Pharmaceuticals: Generic) experienced а +20.50% price change this week, while MKKGY (@Pharmaceuticals: Generic) price change was +1.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

MKKGY is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKKGY($55.5B) has a higher market cap than CPHI($5.46M). MKKGY YTD gains are higher at: -8.380 vs. CPHI (-27.957). MKKGY has higher annual earnings (EBITDA): 5.87B vs. CPHI (-1.74M). MKKGY has more cash in the bank: 1.57B vs. CPHI (625K). CPHI has less debt than MKKGY: CPHI (3.43M) vs MKKGY (9.4B). MKKGY has higher revenues than CPHI: MKKGY (21.2B) vs CPHI (4.4M).
CPHIMKKGYCPHI / MKKGY
Capitalization5.46M55.5B0%
EBITDA-1.74M5.87B-0%
Gain YTD-27.957-8.380334%
P/E RatioN/A16.77-
Revenue4.4M21.2B0%
Total Cash625K1.57B0%
Total Debt3.43M9.4B0%
FUNDAMENTALS RATINGS
CPHI vs MKKGY: Fundamental Ratings
CPHI
MKKGY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
23
Undervalued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
9870
PRICE GROWTH RATING
1..100
6062
P/E GROWTH RATING
1..100
10091
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKKGY's Valuation (23) in the null industry is in the same range as CPHI (46) in the Pharmaceuticals Generic industry. This means that MKKGY’s stock grew similarly to CPHI’s over the last 12 months.

MKKGY's Profit vs Risk Rating (94) in the null industry is in the same range as CPHI (100) in the Pharmaceuticals Generic industry. This means that MKKGY’s stock grew similarly to CPHI’s over the last 12 months.

MKKGY's SMR Rating (70) in the null industry is in the same range as CPHI (98) in the Pharmaceuticals Generic industry. This means that MKKGY’s stock grew similarly to CPHI’s over the last 12 months.

CPHI's Price Growth Rating (60) in the Pharmaceuticals Generic industry is in the same range as MKKGY (62) in the null industry. This means that CPHI’s stock grew similarly to MKKGY’s over the last 12 months.

MKKGY's P/E Growth Rating (91) in the null industry is in the same range as CPHI (100) in the Pharmaceuticals Generic industry. This means that MKKGY’s stock grew similarly to CPHI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPHIMKKGY
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
65%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
54%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
55%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 20 days ago
60%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 14 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GWH1.370.09
+7.03%
ESS Tech
DSX1.670.03
+1.83%
Diana Shipping
RMD277.053.24
+1.18%
ResMed
CNX29.550.15
+0.51%
CNX Resources Corp
URGN18.880.08
+0.43%
UroGen Pharma Ltd

CPHI and

Correlation & Price change

A.I.dvisor tells us that CPHI and ASRT have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPHI and ASRT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPHI
1D Price
Change %
CPHI100%
+16.32%
ASRT - CPHI
24%
Poorly correlated
-1.19%
CRON - CPHI
23%
Poorly correlated
N/A
SXTC - CPHI
22%
Poorly correlated
+16.67%
MKKGY - CPHI
21%
Poorly correlated
+1.66%
AYTU - CPHI
21%
Poorly correlated
-0.44%
More

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
+1.66%
MKGAF - MKKGY
58%
Loosely correlated
+1.49%
LNTH - MKKGY
27%
Poorly correlated
+1.73%
PHCUF - MKKGY
22%
Poorly correlated
N/A
CPHI - MKKGY
22%
Poorly correlated
+16.32%
NPPNY - MKKGY
11%
Poorly correlated
N/A
More